INS and diabetes mellitus: Neutralization of TNFα by intravenous administration of a soluble TNF receptor-immunoglobulin G chimeric protein provided a significant improvement in insulin sensitivity in fatty rats [38–40], but treatment of non-insulin-dependent diabetes mellitus patients with a specific TNFα antibody had no effect on insulin sensitivity [44].